Blocking CD47 not only directly enhances the ability of macrophages to engulf tumor cells, but also activates effector T cells and strengthens the adaptive immune response by facilitating the presentation of tumor antigens on macrophages [40–42]. This evidence concerns the gene CD47 and neoplasm.